ChromaDex to Present at the 37th Annual Roth Conference
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 11 2025
0mins
Source: Newsfilter
ChromaDex Participation at ROTH Conference: ChromaDex Corp. will participate in the 37th Annual ROTH Conference, with CEO Rob Fried speaking on the Longevity and Supplementation Panel on March 17, and management engaging in one-on-one meetings with institutional investors.
About ChromaDex and Niagen: ChromaDex is a leader in NAD+ research and offers Niagen, a clinically proven NAD+ booster sold under the brand Tru Niagen, which aims to enhance healthy aging by increasing NAD+ levels in the body.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
